topic-orcrp001304 News Coverage on AstraZeneca Plc - CTNow
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

AstraZeneca Plc

A collection of news and information related to AstraZeneca Plc published by this site and its partners.

Top AstraZeneca Plc Articles see all

Displaying items 1-5
  • Key Senate Democrat urges action to limit tax inversion 'virus'

    A key Democratic senator on Tuesday decried the recent wave of American companies restructuring abroad to avoid U.S. taxes, describing it as a virus infecting the economy and urging legislation to halt it.
  • Chronic illness education offered for patients, others in Newport News

    Chronic illness education offered for patients, others in Newport News
    Preventing and managing chronic diseases has taken center stage with local health systems trying to control costs and improve outcomes for patients. Bon Secours Mary Immaculate Hospital offers free diabetes management classes on the second and fourth...

    MedImmune expands research with universities

    MedImmune expands research with universities
    Biotechnology company MedImmune said Tuesday it has expanded a bioresearch collaboration it started with the University of System of Maryland. The Gaithersburg company, a development arm of AstraZeneca, started the partnership with the University of...

    Pfizer walks away from AstraZeneca takeover attempt

    Pfizer walks away from AstraZeneca takeover attempt
    Pfizer Inc. said Monday that it had abandoned its current attempt to buy AstraZeneca PLC for nearly $118 billion — a deal watched warily by Maryland officials — as a deadline approached without a last-minute change of heart by the British...

    Pfizer abandons AstraZeneca takeover attempt after rejection

    Pharmaceutical giant Pfizer Inc. has abandoned its effort to buy British rival AstraZeneca for $117 billion in what would have been the biggest deal ever in the drug industry. The offer represented "full value" for AstraZeneca, the New York drug maker...